🇺🇸 FDA
Patent

US 9480673

Composition and method for treating neurodegenerative disease

granted A61KA61K31/19A61K31/192

Quick answer

US patent 9480673 (Composition and method for treating neurodegenerative disease) held by The Regents of the University of Colorado, a Body Corporate expires Mon Oct 27 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Nov 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 27 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/19, A61K31/192, A61K31/21, A61K31/216